Cancer, Bladder Completed Phase 1 Trials for Enoblituzumab (DB15017)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0092003 (Cancer, Bladder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01391143Safety Study of MGA271 in Refractory CancerTreatment